Miguel Viveiros

Has grant

Universidade de Aveiro

Portugal

Research Interests

Explore related searches

Professors in Portugal Professors in Microbiology Microbiology professors in Portugal

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Explorando a inibição de efluxo para o combate à resistência aos antimicrobianos e a biofilmes em estafilococos

Open Date: 2023-01-01

Close Date: 2024-06-30

Grant: Close

Immunotargeting efflux systems for therapeutic modulation of multidrug resistant bacteria

Open Date: 2018-11-15

Close Date: 2021-11-14

Grant: Close

Immunotargeting efflux systems for therapeutic modulation of multidrug resistant bacteria

Open Date: 2018-11-01

Close Date: 2021-11-01

Grant: Close

Imunoterapias contra sistemas de efluxo para modulação de bactérias multiresistentes

Open Date: 2018-11-01

Close Date: 2021-11-01

Grant: Close

O uso de biocidas na prevenção da resistência aos antimicrobianos na comunidade.

Open Date: 2018-10-01

Close Date: 2021-09-01

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (19)

Susana Santos

Universidade de Aveiro

PORTUGAL

View details

Chief Medical Scientist

St George's Hospital

IRELAND

View details

Christian Giske

Professor

Karolinska Institutet

SWEDEN

View details

Katharina Kranzer

Professor of Infectious Disease Epidemiology

London School of Hygiene & Tropical Medicine

UNITED KINGDOM

View details

Rodrigo de Almeida

Universidade de Aveiro

PORTUGAL

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Miguel Viveiros

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (18)

Determinants of vaccine hesitancy among healthcare workers in an international multicenter study within the EuCARE project.

Unlocking the Gates: A Novel Diagnostic Molecule for Quantifying Efflux Levels in Gram‐Positive Bacteria

Evaluation of Amlodipine and Imipramine Efficacy to Treat Galleria mellonella Infection by Biofilm-Producing and Antimicrobial-Resistant Staphylococcus aureus

Dissemination of arr-2 and arr-3 is associated with class 1 integrons in Klebsiella pneumoniae clinical isolates from Portugal.

Molecular Patterns and Antimicrobial Resistance Characterization of Salmonella enterica Non-Typhoidal from Human, Food, and Environment Samples Isolated in Luanda, Angola

Sensitivity profile of pathogens identified in the diagnosis of urinary infection by uroculture carried out at the National Institute for Health Research, Luanda/Angola, during the pre - pandemic, intra - pandemic and post - pandemic of COVID 19

Preliminary structure-activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics

The performance of Xpert MTB/RIF and MTBDRplus within a Programmatic setting at TB Laboratory in Rio de Janeiro, Brazil

Antimicrobial resistance, society and environment: A glocal syndemic

Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution.

Occurrence and Variability of the Efflux Pump Gene norA across the Staphylococcus Genus

Rapid molecular diagnostics to detect resistance to second-line anti-TB drugs.

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates

Updating the approaches to define susceptibility and resistance to anti-tuberculosis agents: implications for diagnosis and treatment.

Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid.

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis

In vitro Evaluation of Isoniazid Derivatives as Potential Agents Against Drug-Resistant Tuberculosis

The Neglected Contribution of Streptomycin to the Tuberculosis Drug Resistance Problem

Collaborators (19)

Susana Santos

Celso Cunha

Maria Santos

Marco Pieroni

Marina Agapito

filomena martins

Ana Armada

Tomasz Jagielski

Henrique Silveira

Inês Fronteira

Sofia Santos Costa

Patrícia Abrantes

Joana Marques

Isabel Couto

Jakko van Ingen

Margaret M Fitzgibbon

Christian Giske

Katharina Kranzer

Rodrigo de Almeida

Make your next move.